• Calypso Biotech SA

    GE
    deleted
    Register number: CH-660.0.621.013-4
    Sector: Research and development

    Age of the company

    -

    Turnover in CHF

    -

    Capital in CHF

    -

    Employees

    -

    Active brands

    -

    Reports for Calypso Biotech SA

    *displayed reports are examples

    There is no information available because this company has been deleted.

    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Shareholder Information

    Find out which national and international companies the stock corporation you are interested in also holds shares in.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    Management

    No managers have been registered.

    Source: SOGC

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Toutes activités en matière de recherche, de développement, de fabrication et de commercialisation de thérapies dans le domaine des sciences de la vie et toutes autres activités liées (cf. statuts pour but complet).

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Former auditor (3)
    Name City Since Until
    KPMG AG
    Basel 10.07.2024 29.06.2025
    PricewaterhouseCoopers SA
    Lausanne 05.12.2018 09.07.2024
    RSM Audit Switzerland SA
    Genève 07.03.2013 04.12.2018

    Other company names

    Source: SOGC

    Past and translated company names

    • Calypso Biotech Ltd
    • Calypso Biotech AG
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Calypso Biotech SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250702/2025 - 02.07.2025
    Categories: Debt call to creditors

    Publication number: SR01-0000014165, Commercial Registry Office Basel-Stadt

    Rubrik: Weitere gesellschaftsrechtliche Schuldenrufe Unterrubrik: Schuldenruf infolge Fusion nach FusG Publikationsdatum: SHAB 02.07.2025, Mehrfache Veröffentlichung: 03.07.2025, 04.07.2025 Öffentlich einsehbar bis: 02.07.2028 Meldungsnummer: Publizierende Stelle Kellerhals Carrard Basel KlG, Henric Petri-Strasse 35, 4051 Basel Schuldenruf infolge Fusion nach FusG Calypso Biotech SA mit Novartis Pharma AG

    1. Veröffentlichung Übertragende Organisation: Calypso Biotech SA CHE-255.501.809 chemin des Aulx 14 1228 Plan-les-Ouates Übernehmende Organisation: Novartis Pharma AG CHE-106.052.527 Lichtstr. 35 4056 Basel Publikation der Fusion im SHAB: 30.06.2025 Rechtliche Hinweise: Aufforderung an die Gläubiger infolge Fusion (Art. 25 Abs. 2 FusG). Die Gläubigerinnen und Gläubiger der an der Fusion beteiligten Parteien können innerhalb der angegebenen Frist Sicherstellung ihrer Forderungen durch die übernehmende Partei verlangen. Frist: 30.09.2025 (3 Monate nach der Rechtswirksamkeit der Fusion) Kontaktstelle:
      Novartis International AG z.H. Corporate and Finance Legal Lichtstrasse 35
    2. Basel

    SOGC 250630/2025 - 30.06.2025
    Categories: Deletion

    Publication number: HR03-1006370473, Commercial Registry Office Geneva, (660)

    Calypso Biotech SA, à Plan-les-Ouates, CHE-255.501.809 (FOSC du 04.02.2025, p. 0/1006247234). Les actifs et les passifs envers les tiers sont repris par Novartis Pharma AG (CHE-106.052.527), à Basel. La société est radiée par suite de fusion.

    SOGC 250204/2025 - 04.02.2025
    Categories: Change in management

    Publication number: HR02-1006247234, Commercial Registry Office Geneva, (660)

    Calypso Biotech SA, à Plan-les-Ouates, CHE-255.501.809 (FOSC du 17.01.2025, p. 0/1006231872). Les pouvoirs de Pfirter Simone Doris sont radiés.

    Title
    Confirm